Key result
In patients with chronic Chagas cardiomyopathy, sustained ventricular tachycardia was associated with a significantly higher number of sympathetic denervation mismatch defects (7.1 vs 2.0; P<0.0001).
Why the study?
Is sustained ventricular tachycardia associated with regional myocardial sympathetic denervation in patients with chronic Chagas cardiomyopathy?
Observational (n=26)
Is sustained ventricular tachycardia associated with regional myocardial sympathetic denervation in patients with chronic Chagas cardiomyopathy?
In patients with chronic Chagas cardiomyopathy and relatively preserved ventricular function, the extent of sympathetically denervated viable myocardium is strongly associated with the presence of sustained ventricular tachycardia.
May aid VT risk stratification via sympathetic imaging in Chagas cardiomyopathy; hypothesis-generating and requires prospective validation.
UNLABELLED: Cardiac sympathetic denervation and ventricular arrhythmia are frequently observed in chronic Chagas cardiomyopathy (CCC). This study quantitatively evaluated the association between cardiac sympathetic denervation and sustained ventricular tachycardia (SVT) in patients with CCC. METHODS: We prospectively investigated patients with CCC and left ventricular ejection fraction (LVEF) greater than 35% with SVT (SVT group: n = 15; mean age ± SD, 61 ± 8 y; LVEF, 51% ± 8%) and patients without SVT (non-SVT group: n = 11; mean age ± SD, 55 ± 10 y; LVEF, 57% ± 10%). Patients underwent myocardial scintigraphy with (123)I-metaiodobenzylguanidine ((123)I-MIBG) for the evaluation of sympathetic innervation and resting perfusion with (99m)Tc-methoxyisobutylisonitrile ((99m)Tc-MIBI) for the evaluation of myocardial viability. A visual semiquantitative score was attributed for regional uptake of each radiotracer using a 17-segment left ventricular segmentation model (0, normal; 4, absence of uptake). A mismatch defect was defined as occurring in segments with a (99m)Tc-MIBI uptake score of 0 or 1 and a (123)I-MIBG score of 2 or more. RESULTS: Compared with the non-SVT group, the SVT group had a similar (99m)Tc-MIBI summed score (6.9 ± 7.5 vs. 4.4 ± 5.2, respectively, P = 0.69) but a higher (123)I-MIBG summed score (10.9 ± 7.8 vs. 22.4 ± 9.5, respectively, P = 0.007) and a higher number of mismatch defects per patient (2.0 ± 2.2 vs. 7.1 ± 2.0, respectively, P < 0.0001). The presence of more than 3 mismatch defects was strongly associated with the presence of SVT (93% sensitivity, 82% specificity; P = 0.0002). CONCLUSION: In CCC, the amount of sympathetically denervated viable myocardium is associated with the occurrence of SVT. Myocardial sympathetic denervation may participate in triggering malignant ventricular arrhythmia in CCC patients with relatively well-preserved ventricular function.
No takes yet. Share an insight, caveat, or question.
Miranda et al. (2011) conducted an observational in Chronic Chagas cardiomyopathy (n=26). Sustained ventricular tachycardia vs. No sustained ventricular tachycardia was evaluated on Number of mismatch defects per patient (p=<0.0001). In patients with chronic Chagas cardiomyopathy, sustained ventricular tachycardia was associated with a significantly higher number of sympathetic denervation mismatch defects (7.1 vs 2.0; P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: